Literature DB >> 1328224

Biochemical properties of the 75-kDa tumor necrosis factor receptor. Characterization of ligand binding, internalization, and receptor phosphorylation.

D Pennica1, V T Lam, N K Mize, R F Weber, M Lewis, B M Fendly, M T Lipari, D V Goeddel.   

Abstract

An expression plasmid encoding the human 75-kDa tumor necrosis factor (TNF) type 2 receptor (TNF-R2) was constructed and used to generate a stable human cell line (293/TNF-R2) overexpressing TNF-R2. Ligand binding analysis revealed high affinity binding (Kd = 0.2 nM) with approximately 94,000 +/- 7,500 sites/cell for 125I-TNF-alpha and approximately 5-fold lower affinity for TNF-beta (Kd = 1.1 nM) with 264,000 +/- 2,000 sites/cell. Cross-linking of 125I-TNF-alpha and 125I-TNF-beta to 293/TNF-R2 cells yielded predominant complexes with apparent molecular weights of 211,000 for TNF-alpha and 205,000 and 244,000 for TNF-beta, suggesting these complexes contain two or three TNF-R2 molecules. Immunoprecipitation of TNF-R2 from 32P-labeled 293/TNF-R2 cells demonstrated that the receptor is phosphorylated. The majority (97%) of 32Pi incorporation was found in serine residues with a very low level of incorporation (3%) in threonine residues. TNF-alpha treatment of 293/TNF-R2 cells did not significantly affect the degree or pattern of phosphorylation. Cell surface-bound 125I-TNF-alpha was slowly internalized by the 293/TNF-R2 cell line with a t1/2 = 25 min. Shedding of the extracellular domain of TNF-R2 was induced by 4 beta-phorbol 12-myristate 13-acetate but not by TNF-alpha or TNF-beta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1328224

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  TNF ligands and receptors--a matter of life and death.

Authors:  David J MacEwan
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction.

Authors:  M Rothe; J Xiong; H B Shu; K Williamson; A Goddard; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

Review 3.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

4.  The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor.

Authors:  M Grell; H Wajant; G Zimmermann; P Scheurich
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

5.  Retrograde transport and steady-state distribution of 125I-nerve growth factor in rat sympathetic neurons in compartmented cultures.

Authors:  D R Ure; R B Campenot
Journal:  J Neurosci       Date:  1997-02-15       Impact factor: 6.167

6.  Tumor necrosis factor alpha-induced activation of c-jun N-terminal kinase is mediated by TRAF2.

Authors:  C Reinhard; B Shamoon; V Shyamala; L T Williams
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

7.  Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma.

Authors:  Mohammad Fallahi-Sichani; Matthew A Schaller; Denise E Kirschner; Steven L Kunkel; Jennifer J Linderman
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

Review 8.  Tumor necrosis factor and stroke: role of the blood-brain barrier.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-08-06       Impact factor: 11.685

9.  Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators.

Authors:  J Bondeson; B Foxwell; F Brennan; M Feldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

10.  NF-κB Signaling Dynamics Play a Key Role in Infection Control in Tuberculosis.

Authors:  Mohammad Fallahi-Sichani; Denise E Kirschner; Jennifer J Linderman
Journal:  Front Physiol       Date:  2012-06-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.